2026 NPPES data Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician NPI 1578906129 M.D.
Verify on CMS →

Joseph Panza, M.D.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in Rochester, New York.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 621 in Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
619
Medicare Part D claims · 193 beneficiaries · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician avg: 661
Industry payments
$528.25
11 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Joseph Panza, M.D. filed 619 Medicare Part D claims in 2024 as a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in Rochester, New York.

619
Part D claims, 2024
Likely
board-certified (heuristic)
≥68th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Joseph Panza, M.D.

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1578906129), first enumerated 04/14/2013.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 619 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $528.25 in reported industry payments (11 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • State context

    State board disciplinary context

    New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Joseph Panza, M.D.'s individual license status. Verify directly with the state medical board.

    Source: NYSBPMC annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1578906129 · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician

NPI-10 · ENUM-MID · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1578906129
  • ENUM-MID 2013
  • TAX-NARROW 621
  • RX-LIGHT 619
  • BOOK-THIN 42 in New York
  • PHOTO-ENUM Patricia Hudson · 2013

Joseph Panza, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

619 ≥ 68th percentile 68% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). Below this entry. 400–600: 95,866 prescribers (7%). Below this entry. 600–800: 60,107 prescribers (4%). This entry sits in this band. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

Joseph Panza, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Joseph Panza, M.D.?

Quality data not reported

NPI registry status

Active

Issued 04/14/2013

NPI 1578906129

Primary specialty

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician

Niche

621 US NPIs in this specialty

Medicare Part D claims

619 6% vs specialty avg

2024 prescription claims

Specialty avg: 661

Specialty distribution in New York

How Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician compares to other specialties among New York providers

New York providers
Student in an Organized Heal…8%Registered Nurse5.2%Clinical Social Worker4.9%Social Worker4.5%Speech-Language Pathologist4.5%Licensed Practical Nurse4.3%Urogynecology and Reconstruc…0%
Largest specialties in New York (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

500 RED CREEK DR STE 120
Rochester, NY 14623

Provider Details

NPI 1578906129
Specialty Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
Credentials M.D.
Gender Male
NPI Issued 04/14/2013

Hospital and facility affiliations

Facilities where Joseph Panza, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

University OF Rochester Obgyn Subspecialties
Rochester, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Joseph Panza, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$528

Largest payer

Boston Scientific Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - New York NYSBPMC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Joseph Panza, M.D.. To verify Joseph Panza, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

619
Total Claims
$163K
Total Drug Cost
193
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
942.8
Total Day Supply
25,402
Generic Drug Cost
$37K
Opioid Claims
12 (1.9% rate)
Antibiotic Claims
106

Patient Demographics

Average Patient Age
72.9 years
Avg HCC Risk Score
1.04
Gender Split
100% female / 0% male
Age Distribution
<65: 22, 65-74: 82, 75-84: 77, 85+: 12

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Joseph Panza, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Myrbetriq
Mirabegron
120
Gemtesa
Vibegron
110
Estradiol
83
Mirabegron Er
Mirabegron
43
Trospium Chloride Er
Trospium Chloride
36
Nitrofurantoin Mono-Macro
Nitrofurantoin Monohyd/M-Cryst
33
Nitrofurantoin
Nitrofurantoin Macrocrystal
30
Solifenacin Succinate
27
Trospium Chloride
22
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Overview

How Joseph Panza, M.D. fits within the Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician landscape nationally.

621
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in US
50
States with Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
661
Avg Claims per Provider

Joseph Panza, M.D.'s 619 claims are below the specialty average of 661.

Nationwide Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Panza, both outside New York so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2013)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Panza.

One of 42 Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers enrolled in New York, 5 are shown here.

Compare Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Joseph Panza, M.D.'s specialty?
Joseph Panza, M.D. specializes in Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician and practices in Rochester, New York. Credentials: M.D..
How much does Joseph Panza, M.D. prescribe under Medicare Part D?
In 2024, Joseph Panza, M.D. wrote 619 Medicare Part D claims totaling $163K in drug costs for 193 beneficiaries.
Where is Joseph Panza, M.D. located?
Joseph Panza, M.D. is located at 500 RED CREEK DR STE 120, Rochester, NY, 14623. Phone: (585) 481-3400.
What is Joseph Panza, M.D.'s NPI number?
Joseph Panza, M.D.'s National Provider Identifier (NPI) is 1578906129, issued on 04/14/2013.
Does Joseph Panza, M.D. prescribe opioids?
Yes, Joseph Panza, M.D. had 12 opioid claims in 2024 with an opioid prescribing rate of 1.9%.
How many Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers are there in the US?
There are 621 Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers across 50 states in the US. The average Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider writes 661 Medicare Part D claims per year.
What drugs does Joseph Panza, M.D. prescribe most often?
Based on 2024 Medicare Part D data, Joseph Panza, M.D.'s most frequently prescribed drugs include Myrbetriq, Gemtesa, Estradiol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Joseph Panza, M.D. accept Medicare?
Joseph Panza, M.D. appears in CMS Medicare data with 619 Part D claims and 193 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Joseph Panza, M.D.'s credentials?
Joseph Panza, M.D.'s NPI is 1578906129 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.